即時凝血檢測設備市場－全球產業規模、佔有率、趨勢、機會和預測（按設備類型、按產品、按最終用戶、按地區和按競爭細分，2020-2030 年）

2024年，全球即時凝血檢測設備市場規模達18.4億美元，預計2030年將達25.8億美元，預測期內複合年成長率為5.79%。受深部靜脈血栓形成 (DVT)、肺栓塞、心肌梗塞、血友病和血管性血友病等血栓和出血性疾病盛行率不斷上升的推動，該市場正經歷著強勁成長勢頭。

由於人口老化和生活方式相關因素，這些疾病日益普遍，需要頻繁且及時地監測凝血功能，尤其是在接受長期抗凝血治療的患者中。急診室、外科病房、抗凝血診所和家庭醫療保健對快速診斷的需求，推動了對能夠在幾分鐘內提供準確結果的即時診斷 (POC) 凝血設備的需求。

推動這一市場發展的顯著趨勢是醫療保健產業正轉向分散式診斷，更青睞攜帶式、易於使用的設備，而非傳統的集中式實驗室檢測。這種轉變正在增強臨床決策能力，最大限度地減少手術延誤，並改善各種護理環境中的患者護理。

關鍵市場促進因素

心血管和止血疾病盛行率上升

主要市場挑戰

設備和耗材成本高

主要市場趨勢

數位連接和遠距醫療解決方案的整合

與這些設備配對的智慧型手機應用程式提供：

• 指導測試程序
• 結果視覺化展示
• 趨勢分析
• 即時警報和通知

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球即時凝血檢測設備市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依設備類型（抗凝血監測設備、血小板功能監測設備、黏彈性凝血監測設備、其他）
  • 按產品（儀器/分析儀、耗材及配件）
  • 按最終使用者（醫院、診所、家庭護理機構、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美即時凝血檢測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲即時凝血檢測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區即時凝血檢測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲即時凝血檢測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲即時凝血檢測設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Werfen, SA
• Siemens Healthineers
• Helena Laboratories Corporation
• Medtronic plc
• Koninklijke Philips NV
• Alere Inc.
• HemoSonics, LLC
• Sysmex Corporation

第 16 章：策略建議

第17章調查會社について,免責事項

The Global Point of Care Coagulation Testing Devices Market was valued at USD 1.84 Billion in 2024 and is projected to reach USD 2.58 Billion by 2030, growing at a CAGR of 5.79% during the forecast period. This market is experiencing strong momentum, driven by the growing prevalence of thrombotic and bleeding disorders such as deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction, hemophilia, and von Willebrand disease.

These conditions, increasingly common due to aging populations and lifestyle-related factors, demand frequent and timely coagulation monitoring-especially among patients undergoing long-term anticoagulant therapies. The need for rapid diagnostics in emergency rooms, surgical units, anticoagulation clinics, and home healthcare is fueling demand for point of care (POC) coagulation devices that deliver accurate results in minutes.

A notable trend driving this market is the healthcare industry's shift toward decentralized diagnostics, favoring portable, easy-to-use devices over traditional, centralized lab testing. This transformation is enhancing clinical decision-making, minimizing procedural delays, and improving patient care across a variety of care settings.

Key Market Drivers

Rising Prevalence of Cardiovascular and Hemostatic Disorders

The rising burden of cardiovascular diseases (CVDs) and hemostatic disorders is a primary growth catalyst. According to the World Health Organization, CVDs are responsible for approximately 17.9 million deaths annually, accounting for 32% of all global fatalities. One-third of these occur prematurely, before the age of 70.

In the United States alone, CVDs caused 930,000 deaths in 2020, making them the leading cause of mortality. Similarly, 2.2 million deaths across the Americas in 2021 were attributed to cardiovascular conditions. Despite a decline in mortality rates over recent decades, the absolute number of cases remains high, driven by aging populations and lifestyle-related risk factors.

Key Market Challenges

High Cost of Devices and Consumables

One of the most significant barriers to market growth is the high cost associated with POC coagulation testing systems. These devices often involve substantial upfront capital investment, particularly when equipped with wireless connectivity, data integration tools, and automated features.

Recurring expenses on test cartridges, reagents, maintenance, and software updates further strain hospital and clinic budgets-particularly in low-resource settings and developing regions. For home users, the cost of consumables over time can lead to reduced testing frequency or non-compliance, which compromises treatment safety and outcomes.

In public healthcare systems where budgets are constrained, procurement decisions often prioritize cost over long-term clinical value. Reimbursement inconsistencies further discourage adoption of these technologies in outpatient and remote care environments. Additionally, premium-priced consumables for advanced coagulation tests such as TEG and ROTEM are often limited to larger, better-funded hospitals.

Key Market Trends

Integration of Digital Connectivity and Telehealth Solutions

One of the most transformative trends reshaping this market is the digital evolution of POC coagulation devices. Modern analyzers now feature Bluetooth and Wi-Fi capabilities, allowing for instant transmission of results to electronic health record (EHR) systems or secure cloud platforms.

This connectivity enables remote patient monitoring, particularly for individuals on anticoagulants such as warfarin or DOACs. Physicians can monitor INR/PT levels in real time, adjust dosages, and enhance treatment compliance-all without in-person visits.

Smartphone apps paired with these devices offer:

• Guided test procedures
• Visual display of results
• Trend analysis
• Real-time alerts and notifications

This ecosystem supports telehealth platforms, enabling virtual consultations and improving access in rural or home-based settings. Remote diagnostics, firmware updates, and device troubleshooting via apps are also streamlining usability and reducing support burdens.

Key Market Players

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Werfen, S.A.
• Siemens Healthineers
• Helena Laboratories Corporation
• Medtronic plc
• Koninklijke Philips N.V.
• Alere Inc.
• HemoSonics, LLC
• Sysmex Corporation

Market Segmentation

By Device Type:

• Anticoagulation Monitoring Devices
• Platelet Function Monitoring Devices
• Viscoelastic Coagulation Monitoring Devices
• Others

By Product:

• Instruments/Analyzers
• Consumables & Accessories

By End User:

• Hospitals
• Clinics
• Home Care Settings
• Others

By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

The report provides detailed profiles and strategic insights for leading companies operating in the Global Point of Care Coagulation Testing Devices Market. Analysis includes product innovation, market positioning, technological advancements, and global footprint.

Available Customizations

TechSci Research offers customizable elements in this report to align with specific business needs. Available options include:

• In-depth analysis and profiling of up to five additional market players

Let me know if you'd like this version adapted into a presentation deck, executive summary, or slide notes for a meeting!

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Point of Care Coagulation Testing Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Anticoagulation Monitoring Devices, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices, Others)
  • 5.2.2. By Product (Instruments/Analyzers, Consumables & Accessories)
  • 5.2.3. By End User (Hospitals, Clinics, Home Care Settings, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Point of Care Coagulation Testing Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type
  • 6.2.2. By Product
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End User

7. Europe Point of Care Coagulation Testing Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type
  • 7.2.2. By Product
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End User

8. Asia-Pacific Point of Care Coagulation Testing Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type
  • 8.2.2. By Product
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End User
  • 8.3.2. India Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End User

9. South America Point of Care Coagulation Testing Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type
  • 9.2.2. By Product
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End User

10. Middle East and Africa Point of Care Coagulation Testing Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type
  • 10.2.2. By Product
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Abbott Laboratories
• 15.3. Werfen, S.A.
• 15.4. Siemens Healthineers
• 15.5. Helena Laboratories Corporation
• 15.6. Medtronic plc
• 15.7. Koninklijke Philips N.V.
• 15.8. Alere Inc.
• 15.9. HemoSonics, LLC
• 15.10. Sysmex Corporation

16. Strategic Recommendations

17. About Us & Disclaimer